Compare BOOM & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOOM | MXCT |
|---|---|---|
| Founded | 1965 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.5M | 86.5M |
| IPO Year | 1995 | 2021 |
| Metric | BOOM | MXCT |
|---|---|---|
| Price | $5.05 | $0.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $8.50 | $7.50 |
| AVG Volume (30 Days) | 397.1K | ★ 1.0M |
| Earning Date | 05-25-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $609,840,000.00 | $38,627,000.00 |
| Revenue This Year | $0.72 | N/A |
| Revenue Next Year | $7.05 | $9.64 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.69 | $0.64 |
| 52 Week High | $9.20 | $3.30 |
| Indicator | BOOM | MXCT |
|---|---|---|
| Relative Strength Index (RSI) | 31.29 | 45.16 |
| Support Level | N/A | $0.75 |
| Resistance Level | $6.95 | $0.88 |
| Average True Range (ATR) | 0.29 | 0.06 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 20.45 | 53.30 |
DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.